Objective:To explore the detection significance of peripheral blood CD64 index,neutrophil/lymphocyte ratio(NLR)and CD14+monocyte human leukocyte antigen DR(HLA-DR)in patients with severe pneumonia.Method:Clinical data of 80 patients with severe pneumonia admitted to First People's Hospital of Fuzhou from January 2022 to March 2024 were collected for study.According to the prognosis of the patients within 28 days,the dead patients were divided into the death group(n=32)and the surviving patients were divided into the survival group(n=48).General data and CD64 index,NLR,CD14+monocyte HLA-DR level were compared between the two groups.The value of CD64 index,NLR,CD14+monocyte HLA-DR alone and combined in predicting the prognosis of severe pneumonia and the risk factors of fatality in patients with severe pneumonia were analyzed.Result:There were significant differences in age,acute physiology and chronic health evaluation Ⅱ(APACHEⅡ)at admission between the two groups(P<0.05).CD64 index and NLR in death group were higher than those in survival group,and CD14+monocyte HLA-DR level was lower than that in survival group(P<0.05).The results of receiver operating characteristics(ROC)curve showed that the area under the curve(AUC)of CD64 index,NLR and CD14+monocyte HLA-DR alone and combined to predict the prognosis of severe pneumonia were 0.812,0.769,0.728 and 0.893,respectively,all of which had certain predictive value(P<0.05).logistic regression analysis showed that CD64 index>9.15,NLR>12.19,CD14+monocyte HLA-DR≤44.60%,age≥65 years old and APACHEⅡ≥21.69 scores at admission were independent risk factors of fatality in patients with severe pneumonia(P<0.05).Conclusion:Low CD14+monocyte HLA-DR level,high CD64 index and NLR suggest that the prognosis of patients with severe pneumonia is poor,and the combined detection of the three can provide reference for clinical prediction of the prognosis of patients with severe pneumonia.
关键词
重症肺炎/CD64指数/中性粒细胞/淋巴细胞比值/CD14+单核细胞人类白细胞DR抗原
Key words
Severe pneumonia/CD64 index/Neutrophil/lymphocyte ratio/CD14+monocyte human leukocyte antigen DR